MET EXON 14 MUTATION

Clinical trials for MET EXON 14 MUTATION explained in plain language.

Never miss a new study

Get alerted when new MET EXON 14 MUTATION trials appear

Sign up with your email to follow new studies for MET EXON 14 MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New hope for rare lung cancer: targeted pill may outperform standard care

Disease control Recruiting now

This study tests whether the targeted drug tepotinib works better than standard treatments for people with advanced non-small cell lung cancer that has a specific MET gene change. About 133 adults whose cancer worsened after initial therapy will be randomly assigned to receive te…

Matched conditions: MET EXON 14 MUTATION

Phase: PHASE3 • Sponsor: Intergroupe Francophone de Cancerologie Thoracique • Aim: Disease control

Last updated May 17, 2026 03:10 UTC

MET EXON 14 MUTATION

Get alerted when new MET EXON 14 MUTATION trials appear

New hope for rare lung cancer: targeted pill may outperform standard care